Details of the Drug Combination
General Information of Drug Combination (ID: DCU06XJ)
Drug Combination Name |
CA4P JQ1
|
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication |
|
|||||||||||||||||
Component Drugs | CA4P | JQ1 | ||||||||||||||||
N.A. | Small molecular drug | |||||||||||||||||
2D MOL | 2D MOL | |||||||||||||||||
3D MOL | 3D MOL | |||||||||||||||||
High-throughput Screening Result | Testing Cell Line: DIPG25 | |||||||||||||||||
Zero Interaction Potency (ZIP) Score: 10.069 | ||||||||||||||||||
Bliss Independence Score: 9.064 | ||||||||||||||||||
Loewe Additivity Score: 8.735 | ||||||||||||||||||
LHighest Single Agent (HSA) Score: 12.339 | ||||||||||||||||||
Molecular Interaction Atlas of This Drug Combination
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication(s) of CA4P |
|
|||||||||||||||||||||||||
Indication(s) of JQ1 |
|
|||||||||||||||||||||||||
JQ1 Interacts with 1 DTT Molecule(s)
|
||||||||||||||||||||||||||
Test Results of This Drug Combination in Other Disease Systems
|
|||||||||||||||||||||||||
References